Yellow fever vaccine-associated viscerotropic disease: Difference between revisions
From IDWiki
(Created page with "== Background == === Risk Factors === * Risk increases with age > 60 years * Thymus disease (thymoma, myasthenia gravis, thymectomy) == Clinical Manifestations == * Incuba...") |
(categories) |
||
| Line 1: | Line 1: | ||
| − | == |
+ | ==Background== |
| − | === |
+ | ===Risk Factors=== |
| − | * |
+ | *Risk increases with age > 60 years |
| − | * |
+ | *Thymus disease (thymoma, myasthenia gravis, thymectomy) |
| − | == |
+ | ==Clinical Manifestations== |
| − | * |
+ | *Incubation period [[Usual incubation period::2 to 5 days]] |
| − | * |
+ | *Characterized by multiorgan failure similar to [[yellow fever]] |
| − | * |
+ | *High mortality 65%, higher in women |
| + | |||
| + | [[Category:Infectious diseases]] |
||
| + | [[Category:Vaccination]] |
||
Latest revision as of 16:55, 10 August 2020
Background
Risk Factors
- Risk increases with age > 60 years
- Thymus disease (thymoma, myasthenia gravis, thymectomy)
Clinical Manifestations
- Incubation period 2 to 5 days
- Characterized by multiorgan failure similar to yellow fever
- High mortality 65%, higher in women
